Have you been vaccinated against Meningococcal Disease? The Holdsworth House Research team are currently recruiting for a study using investigational vaccines against Meningococcal Disease. If you are aged 18-25, have …
CONDITION: Infection
GENDER: Both males and females
AGE GROUP: 18 to 25 years
TRIAL STATUS: Recruiting
OVERVIEW The Holdsworth House Research team are currently seeking volunteers to trial a new possible Type 2 Diabetes therapy. We are seeking patients whose diabetes control could be improved. There …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Researchers at NICM Health Research Institute are seeking participants to join a clinical trial investigating the effectiveness and safety of an herbal medicine for the management of osteoarthritis of the …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 40 to 75 years
TRIAL STATUS: Closed: follow-up complete
Research Centre: NICM Health Research Institute, Western Sydney University Location: Online and via phone. No face to face contact is required with any member of the research team. Lead Doctor: …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Completed
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP: 30 to 65 years
TRIAL STATUS: Completed
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
This is an open-label Phase 1/2 study to assess the safety and tolerability of combination PD-1 inhibitor (nivolumab) administered concomitantly with c-Met inhibitor (APL-101), to determine the recommended Phase 2 …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
POLARIS is a Phase 2 research trial testing a potential new treatment for BRAFV600-mutant positive melanoma that has spread to the brain. The new treatment is called encorafenib (Braftovi) + …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
An Australian researcher is testing an investigational cream for plaque psoriasis. Participants will receive investigational cream (active study drug) or placebo. Investigational medication and study-related care will be provided at …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
The StandingTall team, has worked with over 500 community-dwelling older people since 2015, implementing a home-based balance exercise program delivered through a tablet computer. By embracing technology, we are providing …
CONDITION: Injuries and Accidents
GENDER: Both males and females
AGE GROUP: 65 and above
TRIAL STATUS: Recruiting
Youth aged 12 to 17 with a history of eczema (atopic dermatitis) for at least one year, may qualify to participate in this study. Adolescents must have moderate to severe …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 12 to 17 years
TRIAL STATUS: Active, not recruiting
Update February 2020: Recruitment for this study has now closed. Have you had one or more gout attacks in the past 12 months and do you have access to a …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Join a new research trial Are you suffering pain after Shingles? Have you had shingles on your body? Are you experiencing pain 3 months after an outbreak? If you have …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Join a diabetes trial Living with pain in your feet? Do you have diabetes? Have you had significant pain for at least 6 months or more? If you have answered …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Seeking healthy male participants who do not have any history of asthma or hayfever. The purpose of this study is to investigate a new asthma medication, though at this early …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 55 years
TRIAL STATUS: Recruiting
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
We have completed recruitment for the ‘RESOLVE trial for chronic low back pain’, a commonwealth government funded randomised controlled trial in which we are investigating the effectiveness of new treatment …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Closed: follow-up continuing
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 to 80 years
TRIAL STATUS: Completed
Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
Australian researchers are testing a new oral medication for severe asthma. This is a 52 week study with 11 separate visits and 6 telephone calls. You will be treated at …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 12 and above
TRIAL STATUS: Recruiting
Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 50 and above
TRIAL STATUS: Completed
This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 50 and above
TRIAL STATUS: Completed
This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 6 to 17 years
TRIAL STATUS: Recruiting
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 10 to 18 years
TRIAL STATUS: Recruiting
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of …
CONDITION: Cancer
GENDER: Males
AGE GROUP: 18 and above
TRIAL STATUS: Completed
If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option. Wesley Medical Research are looking for people who are …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting